JP2020508663A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508663A5 JP2020508663A5 JP2019545731A JP2019545731A JP2020508663A5 JP 2020508663 A5 JP2020508663 A5 JP 2020508663A5 JP 2019545731 A JP2019545731 A JP 2019545731A JP 2019545731 A JP2019545731 A JP 2019545731A JP 2020508663 A5 JP2020508663 A5 JP 2020508663A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- fragment
- antibody
- tumor
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 72
- 102000036639 antigens Human genes 0.000 claims 70
- 108091007433 antigens Proteins 0.000 claims 70
- 206010028980 Neoplasm Diseases 0.000 claims 57
- 239000012634 fragment Substances 0.000 claims 54
- 230000003302 anti-idiotype Effects 0.000 claims 44
- 210000004027 cell Anatomy 0.000 claims 38
- 108020001507 fusion proteins Proteins 0.000 claims 30
- 102000037865 fusion proteins Human genes 0.000 claims 30
- -1 TMPRSS-3 / 4 Proteins 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 102000025171 antigen binding proteins Human genes 0.000 claims 16
- 108091000831 antigen binding proteins Proteins 0.000 claims 16
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims 12
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 12
- 102100038358 Prostate-specific antigen Human genes 0.000 claims 12
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims 9
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims 8
- 101710123134 Ice-binding protein Proteins 0.000 claims 8
- 101710082837 Ice-structuring protein Proteins 0.000 claims 8
- 108010017842 Telomerase Proteins 0.000 claims 8
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 8
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 6
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 6
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 6
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 6
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 6
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 6
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 6
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 6
- 229940125644 antibody drug Drugs 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 230000001939 inductive effect Effects 0.000 claims 6
- 238000012737 microarray-based gene expression Methods 0.000 claims 6
- 238000012243 multiplex automated genomic engineering Methods 0.000 claims 6
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 6
- 102000005962 receptors Human genes 0.000 claims 6
- 108020003175 receptors Proteins 0.000 claims 6
- 102000010956 Glypican Human genes 0.000 claims 5
- 108050001154 Glypican Proteins 0.000 claims 5
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 4
- 101800000504 3C-like protease Proteins 0.000 claims 4
- 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 claims 4
- 101710145634 Antigen 1 Proteins 0.000 claims 4
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims 4
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims 4
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 4
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 4
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims 4
- 102000013392 Carboxylesterase Human genes 0.000 claims 4
- 108010051152 Carboxylesterase Proteins 0.000 claims 4
- 101150029707 ERBB2 gene Proteins 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102100035139 Folate receptor alpha Human genes 0.000 claims 4
- 108050007237 Glypican-3 Proteins 0.000 claims 4
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 4
- 101001023230 Homo sapiens Folate receptor alpha Proteins 0.000 claims 4
- 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 claims 4
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims 4
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 4
- 102000004877 Insulin Human genes 0.000 claims 4
- 108090001061 Insulin Proteins 0.000 claims 4
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims 4
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims 4
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 4
- 102100034872 Kallikrein-4 Human genes 0.000 claims 4
- 108010028275 Leukocyte Elastase Proteins 0.000 claims 4
- 102000016799 Leukocyte elastase Human genes 0.000 claims 4
- 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 claims 4
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 4
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 4
- 102100022430 Melanocyte protein PMEL Human genes 0.000 claims 4
- 102100023123 Mucin-16 Human genes 0.000 claims 4
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 4
- 206010060862 Prostate cancer Diseases 0.000 claims 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 4
- 108010002687 Survivin Proteins 0.000 claims 4
- 102100033504 Thyroglobulin Human genes 0.000 claims 4
- 108010034949 Thyroglobulin Proteins 0.000 claims 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims 4
- 229940088598 enzyme Drugs 0.000 claims 4
- 239000003102 growth factor Substances 0.000 claims 4
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims 4
- 210000002865 immune cell Anatomy 0.000 claims 4
- 229940125396 insulin Drugs 0.000 claims 4
- 230000000968 intestinal effect Effects 0.000 claims 4
- 108010024383 kallikrein 4 Proteins 0.000 claims 4
- 230000000873 masking effect Effects 0.000 claims 4
- 101800000607 p15 Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 238000010839 reverse transcription Methods 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 101150047061 tag-72 gene Proteins 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 229960002175 thyroglobulin Drugs 0.000 claims 4
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims 3
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 claims 3
- 208000032612 Glial tumor Diseases 0.000 claims 3
- 206010018338 Glioma Diseases 0.000 claims 3
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims 3
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims 3
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims 3
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims 3
- 102000003735 Mesothelin Human genes 0.000 claims 3
- 108090000015 Mesothelin Proteins 0.000 claims 3
- 230000001086 cytosolic effect Effects 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 3
- 210000000822 natural killer cell Anatomy 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 230000011664 signaling Effects 0.000 claims 3
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims 2
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 2
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims 2
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims 2
- 101710163573 5-hydroxyisourate hydrolase Proteins 0.000 claims 2
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 claims 2
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 claims 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 claims 2
- 102000030431 Asparaginyl endopeptidase Human genes 0.000 claims 2
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims 2
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 2
- 102000015735 Beta-catenin Human genes 0.000 claims 2
- 108060000903 Beta-catenin Proteins 0.000 claims 2
- 102100024210 CD166 antigen Human genes 0.000 claims 2
- 102100024220 CD180 antigen Human genes 0.000 claims 2
- 102100025221 CD70 antigen Human genes 0.000 claims 2
- 102100036369 Carbonic anhydrase 6 Human genes 0.000 claims 2
- 102000011727 Caspases Human genes 0.000 claims 2
- 108010076667 Caspases Proteins 0.000 claims 2
- 102000005600 Cathepsins Human genes 0.000 claims 2
- 108010084457 Cathepsins Proteins 0.000 claims 2
- 102100039496 Choline transporter-like protein 4 Human genes 0.000 claims 2
- 102100024292 Cryptic family protein 1B Human genes 0.000 claims 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims 2
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 claims 2
- 108010055196 EphA2 Receptor Proteins 0.000 claims 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims 2
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 2
- 102100028073 Fibroblast growth factor 5 Human genes 0.000 claims 2
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 claims 2
- 102100039717 G antigen 1 Human genes 0.000 claims 2
- 101710113436 GTPase KRas Proteins 0.000 claims 2
- 102100040510 Galectin-3-binding protein Human genes 0.000 claims 2
- 101710197901 Galectin-3-binding protein Proteins 0.000 claims 2
- 101710088083 Glomulin Proteins 0.000 claims 2
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims 2
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 claims 2
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims 2
- 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 claims 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 2
- 101100165850 Homo sapiens CA9 gene Proteins 0.000 claims 2
- 101000980840 Homo sapiens CD166 antigen Proteins 0.000 claims 2
- 101000980829 Homo sapiens CD180 antigen Proteins 0.000 claims 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims 2
- 101000714525 Homo sapiens Carbonic anhydrase 6 Proteins 0.000 claims 2
- 101000910338 Homo sapiens Carbonic anhydrase 9 Proteins 0.000 claims 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims 2
- 101000980071 Homo sapiens Cryptic family protein 1B Proteins 0.000 claims 2
- 101000886137 Homo sapiens G antigen 1 Proteins 0.000 claims 2
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 2
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims 2
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 claims 2
- 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 claims 2
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims 2
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 2
- 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 claims 2
- 101000851058 Homo sapiens Neutrophil elastase Proteins 0.000 claims 2
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 claims 2
- 101000973629 Homo sapiens Ribosome quality control complex subunit NEMF Proteins 0.000 claims 2
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims 2
- 101000847107 Homo sapiens Tetraspanin-8 Proteins 0.000 claims 2
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 claims 2
- 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 claims 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 2
- 101000671653 Homo sapiens U3 small nucleolar RNA-associated protein 14 homolog A Proteins 0.000 claims 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 241000701806 Human papillomavirus Species 0.000 claims 2
- 108010052919 Hydroxyethylthiazole kinase Proteins 0.000 claims 2
- 108010027436 Hydroxymethylpyrimidine kinase Proteins 0.000 claims 2
- 108010030506 Integrin alpha6beta4 Proteins 0.000 claims 2
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 2
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims 2
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims 2
- 108010010995 MART-1 Antigen Proteins 0.000 claims 2
- 102000016200 MART-1 Antigen Human genes 0.000 claims 2
- 102100025136 Macrosialin Human genes 0.000 claims 2
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 claims 2
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 claims 2
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 2
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims 2
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims 2
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 2
- 102100035486 Nectin-4 Human genes 0.000 claims 2
- 101710043865 Nectin-4 Proteins 0.000 claims 2
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 2
- 102100040120 Prominin-1 Human genes 0.000 claims 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 claims 2
- 102100022213 Ribosome quality control complex subunit NEMF Human genes 0.000 claims 2
- 108091007561 SLC44A4 Proteins 0.000 claims 2
- 101100148976 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SDS22 gene Proteins 0.000 claims 2
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 claims 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims 2
- 102100035721 Syndecan-1 Human genes 0.000 claims 2
- 101150031162 TM4SF1 gene Proteins 0.000 claims 2
- 102100032802 Tetraspanin-8 Human genes 0.000 claims 2
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 claims 2
- 102100034902 Transmembrane 4 L6 family member 1 Human genes 0.000 claims 2
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims 2
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 claims 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 2
- 102000003425 Tyrosinase Human genes 0.000 claims 2
- 108060008724 Tyrosinase Proteins 0.000 claims 2
- 102100040099 U3 small nucleolar RNA-associated protein 14 homolog A Human genes 0.000 claims 2
- 102100022962 Vam6/Vps39-like protein Human genes 0.000 claims 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 2
- 108010055066 asparaginylendopeptidase Proteins 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 108091007231 endothelial receptors Proteins 0.000 claims 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 2
- 102000052502 human ELANE Human genes 0.000 claims 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 2
- 229940012957 plasmin Drugs 0.000 claims 2
- 108010014186 ras Proteins Proteins 0.000 claims 2
- 102000016914 ras Proteins Human genes 0.000 claims 2
- 108010020589 trehalose-6-phosphate synthase Proteins 0.000 claims 2
- 101100243447 Arabidopsis thaliana PER53 gene Proteins 0.000 claims 1
- 108010029697 CD40 Ligand Proteins 0.000 claims 1
- 102100032937 CD40 ligand Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims 1
- 102100025137 Early activation antigen CD69 Human genes 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims 1
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims 1
- 102100025323 Integrin alpha-1 Human genes 0.000 claims 1
- 108010041341 Integrin alpha1 Proteins 0.000 claims 1
- 108010055795 Integrin alpha1beta1 Proteins 0.000 claims 1
- 102000000510 Integrin alpha3 Human genes 0.000 claims 1
- 108010041357 Integrin alpha3 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108010000851 Laminin Receptors Proteins 0.000 claims 1
- 102000002297 Laminin Receptors Human genes 0.000 claims 1
- 102000018697 Membrane Proteins Human genes 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 108010008707 Mucin-1 Proteins 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 claims 1
- 108091008874 T cell receptors Proteins 0.000 claims 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 101150080074 TP53 gene Proteins 0.000 claims 1
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 1
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000020411 cell activation Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762462098P | 2017-02-22 | 2017-02-22 | |
| US62/462,098 | 2017-02-22 | ||
| US201762541439P | 2017-08-04 | 2017-08-04 | |
| US62/541,439 | 2017-08-04 | ||
| PCT/US2018/019281 WO2018156802A1 (en) | 2017-02-22 | 2018-02-22 | Compositions and methods for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508663A JP2020508663A (ja) | 2020-03-26 |
| JP2020508663A5 true JP2020508663A5 (enExample) | 2021-04-08 |
Family
ID=63253021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545731A Pending JP2020508663A (ja) | 2017-02-22 | 2018-02-22 | 癌の治療のための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210130494A1 (enExample) |
| EP (1) | EP3585817A4 (enExample) |
| JP (1) | JP2020508663A (enExample) |
| KR (1) | KR20200003367A (enExample) |
| CN (1) | CN110637033A (enExample) |
| AU (1) | AU2018225164A1 (enExample) |
| BR (1) | BR112019017403A2 (enExample) |
| CA (1) | CA3054304A1 (enExample) |
| CL (1) | CL2019002368A1 (enExample) |
| IL (1) | IL268814A (enExample) |
| MA (1) | MA47613A (enExample) |
| MX (1) | MX2019010040A (enExample) |
| WO (1) | WO2018156802A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL270743B2 (en) | 2017-05-19 | 2024-09-01 | Wuxi Biologics Shanghai Co Ltd | Monoclonal antibodies to cytotoxic t-lymphocyte-associated protein 4 (ctla-4), compositions containing same and uses thereof |
| WO2019118918A1 (en) * | 2017-12-15 | 2019-06-20 | Aleta Biotherapeutics Inc. | Cd19 variants |
| CN109504660B (zh) * | 2018-11-02 | 2021-08-06 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
| JP7649239B2 (ja) * | 2018-11-30 | 2025-03-19 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | キメラ抗原受容体ファクトリおよびその使用方法 |
| WO2020113063A1 (en) | 2018-11-30 | 2020-06-04 | Aleta Biotherapeutics Inc. | Single domain antibodies against cll-1 |
| BR112021012631A2 (pt) | 2018-12-26 | 2021-12-14 | Xilio Dev Inc | Anticorpos anti-ctla4 e métodos de uso dos mesmos |
| US12590135B2 (en) | 2019-03-01 | 2026-03-31 | Universität Für Bodenkultur Wien | Stabilized extracellular domain of CD19 |
| CN110256582B (zh) * | 2019-07-10 | 2021-09-17 | 杭州普科亭生物医药有限公司 | 包含cd28和4-1bb的嵌合抗原受体及其应用 |
| US12702708B2 (en) | 2019-08-21 | 2026-08-11 | Innovative Cellular Therapeutics Holdings, Ltd. | Presenting cell and use thereof in cell therapy |
| WO2021113776A1 (en) * | 2019-12-06 | 2021-06-10 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to bcma-targeted binding domains and related compositions and methods |
| CN122150591A (zh) * | 2020-06-08 | 2026-06-05 | 詹森生物科技公司 | 用于测定表达嵌合抗原的免疫细胞的体外肿瘤杀伤活性的基于细胞的测定法 |
| EP4210733B1 (en) | 2020-09-04 | 2024-11-06 | Miltenyi Biotec B.V. & Co. KG | System for inducible expression of an adapter in immune cells |
| EP4211164A1 (en) | 2020-09-14 | 2023-07-19 | Vor Biopharma Inc. | Single domain antibodies against cd33 |
| TW202241935A (zh) | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
| CN115128267B (zh) * | 2021-03-25 | 2025-11-14 | 青岛海兰深生物科技有限公司 | 检测抗乳腺癌天然抗体的检测试剂、试剂盒及其应用 |
| US20240181055A1 (en) * | 2021-04-08 | 2024-06-06 | Crage Medical Co., Limited | Cellular immunotherapy use |
| BR112023025020A2 (pt) * | 2021-06-01 | 2024-02-20 | Janssen Biotech Inc | Anticorpos anti-idiotípicos contra anticorpos anti-cd79b |
| JP2025513855A (ja) | 2022-04-11 | 2025-04-30 | ブイオーアール バイオファーマ インコーポレーテッド | 結合剤及びその使用方法 |
| CN115725738B (zh) * | 2022-08-17 | 2026-06-12 | 深圳市龙岗区耳鼻咽喉医院 | 一种长链非编码rna分子标志物组合及其应用 |
| EP4713363A1 (en) | 2023-05-15 | 2026-03-25 | Syzygymed Inc | Egf-like module containing mucin-like hormone-like 2 (erm2) binding agents and methods of use thereof |
| EP4470555A1 (en) | 2023-05-31 | 2024-12-04 | Miltenyi Biotec B.V. & Co. KG | Anti-tag chimeric antigen receptors with specificity for mutated peptides derived from human fgfr2 |
| WO2026131594A1 (en) * | 2024-12-19 | 2026-06-25 | Lakefront Biotherapeutics Nv | Novel bispecific anti cd19-cd20 car-t constructs and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997034636A1 (en) * | 1996-03-20 | 1997-09-25 | Immunomedics, Inc. | Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| WO2005067980A2 (en) * | 2004-01-12 | 2005-07-28 | Pointilliste, Inc. | Design of therapeutics and therapeutics |
| GB0404187D0 (en) * | 2004-02-25 | 2004-03-31 | Biotransformations Ltd | Binding agents |
| EP2190861A4 (en) * | 2007-08-22 | 2011-03-30 | Univ California | ACTIVE BINDING POLYPEPTIDES AND METHOD FOR THEIR IDENTIFICATION AND USE |
| EP3543256A1 (en) * | 2009-01-12 | 2019-09-25 | Cytomx Therapeutics Inc. | Modified antibody compositions, methods of making and using thereof |
| US11492383B2 (en) * | 2011-06-24 | 2022-11-08 | Stephen D. Gillies | Light chain immunoglobulin fusion proteins and methods of use thereof |
| GB201203442D0 (en) * | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| CA2913052A1 (en) * | 2013-05-24 | 2014-11-27 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor-targeting monoclonal antibodies |
| DK3105317T3 (en) * | 2014-02-14 | 2019-01-14 | Cellectis | Immunotherapy cells that are genetically engineered to target antigen on both immune cells and pathological cells |
| CA2955947A1 (en) * | 2014-07-25 | 2016-01-28 | Cytomx Therapeutics, Inc. | Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same |
| CN107709356A (zh) * | 2015-06-26 | 2018-02-16 | 南加利福尼亚大学 | 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞 |
| WO2017075537A1 (en) * | 2015-10-30 | 2017-05-04 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
| WO2017162587A1 (en) * | 2016-03-22 | 2017-09-28 | F. Hoffmann-La Roche Ag | Protease-activated t cell bispecific molecules |
| WO2017177337A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
-
2018
- 2018-02-22 EP EP18758228.3A patent/EP3585817A4/en not_active Withdrawn
- 2018-02-22 JP JP2019545731A patent/JP2020508663A/ja active Pending
- 2018-02-22 AU AU2018225164A patent/AU2018225164A1/en not_active Abandoned
- 2018-02-22 US US16/487,750 patent/US20210130494A1/en not_active Abandoned
- 2018-02-22 CA CA3054304A patent/CA3054304A1/en not_active Abandoned
- 2018-02-22 BR BR112019017403A patent/BR112019017403A2/pt not_active IP Right Cessation
- 2018-02-22 MX MX2019010040A patent/MX2019010040A/es unknown
- 2018-02-22 WO PCT/US2018/019281 patent/WO2018156802A1/en not_active Ceased
- 2018-02-22 KR KR1020197027551A patent/KR20200003367A/ko not_active Withdrawn
- 2018-02-22 CN CN201880025774.6A patent/CN110637033A/zh active Pending
- 2018-02-22 MA MA047613A patent/MA47613A/fr unknown
-
2019
- 2019-08-21 IL IL26881419A patent/IL268814A/en unknown
- 2019-08-22 CL CL2019002368A patent/CL2019002368A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504628A5 (enExample) | ||
| JP2022515194A5 (enExample) | ||
| JP2018518978A5 (enExample) | ||
| JP7267321B2 (ja) | 改善された特異性を有する改変型ｔリンパ球 | |
| US11806365B2 (en) | Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosis | |
| US20210309966A1 (en) | Methods of improving vector transduction efficiency into t lymphocytes | |
| AU2016343809B2 (en) | Compositions and methods for treatment of cancer | |
| CN105418765B (zh) | Cd19靶向性的嵌合抗原受体和nkt细胞及其制法和应用 | |
| WO2018121604A1 (zh) | 一种多靶点嵌合抗原受体 | |
| WO2018121605A1 (zh) | 一种多功能蛋白质 | |
| CN110637033A (zh) | 用于治疗癌症的组合物和方法 | |
| AU2013204923A1 (en) | Modified t lymphocytes having improved specificity | |
| WO2024019984A1 (en) | Cytokine receptor switch polypeptides and uses thereof | |
| WO2023278893A1 (en) | Adoptive immunotherapy compositions and methods of tracking | |
| CN106478823B (zh) | Her1靶向性的嵌合抗原受体和nkt细胞及其制法和应用 | |
| AU2024350024A1 (en) | Enriched t-cell populations | |
| Bose et al. | Abstract B29: Innate immune modulation: The novel immunotherapeutic Imprime PGG triggers the anti-cancer immunity cycle in concert with tumor-targeting, anti-angiogenic and checkpoint inhibitor antibodies | |
| Atherton et al. | Abstract B096: Oncolytic vaccination for HPV induced cancer | |
| NZ712373B2 (en) | Modified t lymphocytes | |
| HK1234782B (en) | Methods of improving vector transduction efficiency into t lymphocytes | |
| HK1234782A1 (en) | Methods of improving vector transduction efficiency into t lymphocytes | |
| HK1218049B (en) | Modified t lymphocytes having improved specificity |